Radiotherapy and Oncology

Publication Venue For

• Causal relation between heart irradiation and survival of lung cancer patients after radiotherapy 2022
• MO-0471 Motion management in liver SBRT and its impact on treatment time 2022
• MO-0649 Feasibility of MR-guided stereotactic ablative body radiotherapy of lymph node oligometastases 2022
• MO-0711 Impact of operability and total metastatic ablation on outcomes after SABR for oligometastases 2022
• MO-0889 Validation and clinical impact of a novel hybrid cardiac substructure automatic segmentation method 2022
• Magnetic resonance imaging (MRI) guided proton therapy: A review of the clinical challenges, potential benefits and pathway to implementation 2022
• OC-0754 TRIPOD level-4 validation for a larynx cancer survival model using distributed learning 2022
• OC-0756 Development and implementation of a hybrid method for automatic cardiac substructure segmentation 2022
• Open-source distributed learning validation for a larynx cancer survival model following radiotherapy 2022
• PD-0325 Feasibility and safety of MR-guided stereotactic ablative body radiotherapy for Prostate Cancer 2022
• PD-0334 Feasibility of magnetic resonance-guided stereotactic ablative body radiotherapy of liver cancer 2022
• PO-1037 Patterns of care and acute toxicity of MR-Linac: Initial results from the first 1000 fractions 2022
• PO-1064 A Registry for Analysis of Data to Advance Personalised Therapy with MR-Linac (ADAPT-MRL) 2022
• PO-1374 Feasibility of magnetic resonance-guided adaptive post-prostatectomy radiotherapy 2022
• PO-1558 Fast dose predictions with generative adversarial networks for treatment planning of novel therapies 2022
• PO-1618 Standardising Nomenclatures in Breast Radiotherapy Imaging Data using Machine Learning Algorithms 2022
• PO-1706 Designing a national end-to-end audit for respiratory motion management 2022
• Variability of gross tumour volume delineation: MRI and CT based tumour and lymph node delineation for lung radiotherapy 2022
• A systematic review and meta-analysis of the prognostic value of radiomics based models in non-small cell lung cancer treated with curative radiotherapy 2021
• MLC tracking for lung SABR is feasible, efficient and delivers high-precision target dose and lower normal tissue dose 2021
• OC-0335 Final results of TROG 13.01 SAFRON II: Single vs multi-fraction SABR for pulmonary oligometastases 2021
• OC-0398 Stability of multiparametric MR imaging biomarker-derived dose prescriptions for glioblastoma 2021
• OC-0426 Prospective knowledge-based planning for personalised plan QA in a multi-centre kidney SABR trial 2021
• PD-0730 Convolutional Neural Network to predict Deep Inspiration Breath Hold eligibility using Chest X-Ray 2021
• PD-0851 Clinical outcomes of online adaptive RT and conventional RT for muscle invasive bladder cancer. 2021
• PD-0855 First patient experience with real-time EPID-based breath hold monitoring during breast radiotherapy 2021
• PD-0879 Clinical outcomes of neoadjuvant chemoradiation in oesophageal cancer 2021
• PD-0899 Report dose-to-medium in clinical trials; a consensus from the Global Harmonisation Group 2021
• PH-0163 1.5 T MR Linac RO-Lite Workflow 2021
• PH-0225 TROG 14.04: Multicentre study of feasibility and impact on anxiety of DIBH in breast cancer patients 2021
• PH-0544 Clinical impacts of managing motion in kidney stereotactic ablative body radiotherapy 2021
• PO-1155 Real world radiotherapy protocol compliance for patients with Stage I-III Non-Small Cell Lung cancer 2021
• PO-1200 Development and validation of two Australian models to predict 2-year survival in stage I-III NSCLC 2021
• PO-1205 Factors predicting pathological response after neoadjuvant chemoradiation in oesophageal cancer 2021
• PO-1558 MR Linac Stereotactic Prostate:Accumulated dose comparison of adaptive versus non adaptive treatment 2021
• PO-1602 Dosimetric impact of liquid Helium top-up for a 1.5 T MR Linac 2021
• PO-1683 Spatial Characterization of errors in pseudo-CT generation for MRI-only radiotherapy 2021
• PO-1790 Alpha-Beta ratio estimation and radiotherapeutic equivalence of chemotherapy in oesophageal cancer 2021
• PO-1802 Deep learning using Pre-NACRT imaging can predict pathological response in esophageal cancer 2021
• Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency 2021
• SP-0056 In vivo HDR brachytherapy source tracking with point dosimeters: current status and future directions 2021
• Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial 2020
• OC-0337: First in Human: Patient Adaptive 4D Cone Beam CT (4DCBCT) 2020
• OC-0354: Cautiously optimistic: A survey of radiation oncology professionals’ perceptions of automation 2020
• PH-0045: Characterization of proton, carbon and silicon ion beams using scCVD diamond-based microdosimeters 2020
• PH-0049: Organic semiconductors photodiodes for ionising radiation dosimetry 2020
• PH-0406: An IPEM international survey of MRI use for external beam RT treatment planning 2020
• PH-0595: Cardiovascular sequelae after adjuvant therapy in a 10-year cohort of breast cancer patients. 2020
• PH-0650: External validation of survival of lung cancer patients due to setup uncertainties towards the heart 2020
• PO-0799: Target delineation uncertainties using MRI for H&N cancer patients 2020
• PO-1464: Total body irradiation practice in Australia and New Zealand: Results of a Survey 2020
• PO-1484: MRI only based planning to decrease toxicity in prostate cancer IMRT/IGRT: a dosimetric study 2020
• PO-1606: Measurement of dose distribution of cardiosynchronous brain motion in microbeam radiation therapy 2020
• Relationships between rectal and perirectal doses and rectal bleeding or tenesmus in pooled voxel-based analysis of 3 randomised phase III trials 2020
• Towards real time in-vivo rectal dosimetry during trans-rectal ultrasound based high dose rate prostate brachytherapy using MOSkin dosimeters 2020
• Both four-dimensional computed tomography and four-dimensional cone beam computed tomography under-predict lung target motion during radiotherapy 2019
• EP-1164 Estimated benefit of proton therapy and dose de-escalation in HPV p16-positive oropharyngeal cancer 2019
• EP-1333 Myocardial changes detected using Cardiac MRI in left breast patients treated with Radiation 2019
• EP-1771 Measuring the influence of magnetic fields on the dose distributions of clinical electron beams 2019
• EP-1814 On the aperture shape controller and the air cavity correction for lung plans using AcurosXB and AAA 2019
• OC-024: Changes in brain tumour perfusion and diffusion characteristic during treatment 2019
• OC-0298 MLC tracking for lung cancer SABR is clinically feasible: results of first-in-human clinical trial 2019
• OC-049: Avoiding garbage in: A consensus workshop for refining gastric cancer radiotherapy atlas data 2019
• OC-0521 SRS plan quality with variation in modality: Results of an international planning competition 2019
• OC-0603 A 2018 IPEM audit of M RI in external beam radiotherapy treatment planning in the UK 2019
• OC-0608 Credentialing of spine stereotactic ablative body radiotherapy in a multi-centre trial 2019
• PO-0842 Real-Time tracking improves treatment: The TROG Stereo Prostate Ablative Radiotherapy with KIM trial 2019
• PO-1007 Comparison of deep learning with three other methods to generate pseudo-CT for MRI-only radiotherapy 2019
• PO-1128 Clinical implementation of deformable image registration (DIR) 2019
• PV-0428 A multi-centre study for implementation of MRI-only prostate planning 2019
• Quantification of cardiac subvolume dosimetry using a 17 segment model of the left ventricle in breast cancer patients receiving tangential beam radiotherapy 2019
• EP-1306: Cardiovascular sequelae in breast cancer patients receiving adjuvant therapy 2018
• EP-1309: Myocardial segmental strain changes detected with cardiac MRI following tangential breast radiation 2018
• EP-1404: Non-linear radiomic signatures characterizing overall survival from non-small cell lung cancer 2018
• EP-1614: Inter-observer contouring variation of multiple pelvic structures on CT and MR for prostate cancer 2018
• EP-1777: Dosimetric characterisation and clinical commissioning of a high-field inline MRI-Linac 2018
• EP-2127: Feasibility of Automatic Multi-Atlas Based Cardiac Segmentation in Planning CT 2018
• EP-2145: Understanding variation in CT radiomics features – a potential method to reduce feature space 2018
• EP-2150: Can contouring probability maps be a predictor for prostate cancer treatment outcome and toxicity? 2018
• EP-2189: Action levels of robotic small animal irradiator performance derived from 4 years of QA measurements 2018
• EP-2369: Dosimetric impact of imaging modality (CT versus MRI) for cervical cancer radiotherapy 2018
• OC-0177: Mid-treatment response assessment is predictive in HPV negative oropharyngeal cancers undergoing RT 2018
• OC-0295: The feasibility of volumetric 4DMRI in upper abdominal radiation therapy treatment planning 2018
• PO-0757: Non-small cell lung cancer decision support based on distributed learning over multi-center data 2018
• PO-0823: TRAC: Automated atlas based machine learning QA of contouring accuracy for the PROMETHEUS trial 2018
• PO-0979: Ultra-high field MRI for evaluation of rectal cancer stroma ex vivo: correlation with histopathology 2018
• PO-1030: BrachyView: verification of a full LDR brachytherapy patient plan in a prostate gel phantom 2018
• EP-1211: How selected are patients in clinical trials of radiotherapy for non-small cell lung cancer? 2017
• EP-1477: Evaluating gamma-index quality assurance methods for Nasopharynx Volumetric Arc Therapy (VMAT) 2017
• EP-1534: Automate the Complex Stuff: Pathways, Pitfalls and Results of Planning Automation in Raystation 2017
• EP-1583: Quantifying Plan Quality Metrics using Conventional and Stereotactic dosimetric indices in Lung SBRT 2017
• EP-1623: SeedTracker: Enabling real time position monitoring with a conventional linacs for prostate SBRT 2017
• Intensity-based dual model method for generation of synthetic CT images from standard T2-weighted MR images – Generalized technique for four different MR scanners 2017
• MLC tracking for lung SABR reduces planning target volumes and dose to organs at risk 2017
• OC-0260: Experimental verification of dose enhancement effects in a lung phantom from inline magnetic fields 2017
• OC-0343: Experimental setup to measure magnetic field effects of proton dose distributions: simulation study 2017
• OC-0442: Intensity based synthetic CT generation from standard T2-weighted MR images with three MR scanners 2017
• PO-0615: Can diffusion-weighted MRI predict for xerostomia and QoL in head and neck patients receiving RT? 2017
• PO-0808: Comparison of multi-institutional QA for VMAT of Nasopharynx with simulated delivery errors 2017
• PO-0859: Impact of 4DCBCT reconstruction algorithm and surrogate on motion representation 2017
• PV-0240: A logistic regression model to predict 30-day mortality: difference between routine and trial data 2017
• 107 Correlation of Gross Tumour Volume and metabolic Tumour Volume for non-small cell lung cancer patients 2016
• 150 Progress with MRI-linac image-guided radiation dose imaging 2016
• 160 MRI Guided Proton Therapy: pencil beam scanning in an MRI fringe field 2016
• 161 Monte Carlo study of a high resolution monolithic silicon diode array for MRI-linac applications 2016
• 204 Fast Beam Profile Monitors for Microbeam Radiation Therapy 2016
• EP-1095: Prognostic role of FDG PET-CT performed before and during radiotherapy for nasopharyngeal cancer 2016
• EP-1096: Prognostic value of pretreatment FDG-PET features in laryngeal cancer patients treated with RT 2016
• EP-1559: The Australian Clinical Dosimetry Service: The findings from a national auditing service 2016
• EP-1727: A decision support system for localised prostate cancer treated by external beam radiation therapy 2016
• EP-1896: An atlas based auto-contouring technique incorporating interobserver variation 2016
• EP-1906: Importance of true cord delineation in spine SBRT and rigid vs. deformable MRI-to-CT registration 2016
• EP-1929: Characterisation of a gridded electron gun in magnetic fields: implications for MRI-Linac therapy 2016
• EP-1930: Cancer patient experience of slow, single arc rotation to simplify radiation therapy delivery 2016
• Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose-response relationship 2016
• OC-0097: Radiation dose-volume effects for liver SBRT 2016
• PO-0677: Comparing detailed cardiac structure dose-volume metrics in supine versus prone breast irradiation 2016
• PO-0845: Evaluating dosimetric indices in lung SBRT for establishing treatment plan quality guidelines 2016
• PO-0921: Free-breathing dynamic contrast enhanced MRI of lung cancer 2016
• PO-0951: Radiation beam alignment and baseline dosimetry measurements for the Australian MRI-linac program 2016
• PO-1017: Survey of image-guided radiation therapy use in Australia 2016
• PV-0328: Rectal immobilisation device in stereotactic prostate treatment: intrafraction motion and dosimetry 2016
• Prognostic utility of ¹⁸F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site 2016
• EP-1442: Investigating the impact of treatment delivery uncertainties for lung SABR: a pilot study 2015
• EP-1472: Do 4DCT and CBCT imaging doses need to be included in the planning of radiotherapy treatments? 2015
• EP-1530: Limitations of deformable image registration in 4D PET V/Q imaging for functional assessment in lung radiotherapy 2015
• High-resolution pulmonary ventilation and perfusion PET/CT allows for functionally adapted intensity modulated radiotherapy in lung cancer 2015
• OC-0152: Are correction factors needed for microDiamond detectors in small fields? 2015
• OC-0175: In vivo rectal dose measures compared to planned and reconstructed doses in US-based HDR prostate brachytherapy 2015
• OC-0272: "Magic phantom" - a quality assurance system for high dose rate brachytherapy 2015
• OC-0406: Efficient quality management program for long-term consistency of robotic image-guided small animal irradiators 2015
• OC-0551: High spatial and timing resolution silicon based dosimeter for quality assurance of real time adaptive radiotherapy 2015
• PD-0422: Validating a 2 year survival prediction model for laryngeal carcinoma patients in a clinical care and trial setting 2015
• PO-0716: Kidney function loss is directly dose dependent after SBRT for primary RCC as assessed by Cr-51 EDTA + DMSA SPECT/CT 2015
• PO-0873: The treatment of a paediatric Rhabdomyosarcoma in Australasia: a novel physics challenge 2015
• PO-0955: Comparing lung function changes between serial CT-ventilation and Galligas Ventilation PET/CT 2015
• SP-0021: Generation of density maps for dose calculations from MRI using atlas methods 2015
• A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed 2014
• A multi-institutional dosimetry audit of rotational intensity-modulated radiotherapy 2014
• Conventional margins not sufficient for post-prostatectomy prostate bed coverage: An analysis of 477 cone-beam computed tomography scans 2014
• EP-1160: Endobronchial implantation of fiducial markers for image guidance in lung cancer radiotherapy 2014
• EP-1400: Stereotactic radiotherapy for primary renal cell carcinoma: Technique and early toxicity in a single institution 2014
• EP-1693: Biological imaging for focal brachytherapy for prostate cancer 2014
• EP-1712: An assessment of three diffusion weighted imaging sequences for prostate radiotherapy planning 2014
• EP-1759: Integration of DICOM images in a Geant4 application : A support forintra-operative radiotherapy clinical research 2014
• OC-0063: Rapid learning in practice: A lung cancer survival decision support system in routine patient care data 2014
• PD-0035: Characterisation of a scintillation detector for stereotactic field in-air output ratios 2014
• PD-0189: US-probe integrated MOSkin detectors for rectal wall in vivo dosimetry in HDR prostate brachytherapy 2014
• PD-0353: CT substitute derived from MRI for external beam prostate radiotherapy 2014
• PD-0517: Memory preservation in patients with brain metastases following hippocampal avoidance whole-brain RT 2014
• PO-0661: CogState computerized memory tests in patients with br ain metastases: Secondary endpoint results of RTOG 0933 2014
• PO-0794: Detector choice for small-field Stereotactic Radiosurgery (SRS) beam characterisation 2014
• PO-0913: Commissioning and acceptance testing of a dedicated 3T MRI simulator for radiotherapy treatment planning 2014
• Radiation therapy quality assurance in clinical trials - Global harmonisation group 2014
• Risk factors for radiotherapy incidents and impact of an online electronic reporting system 2014
• The outcome of a multi-centre feasibility study of online adaptive radiotherapy for muscle-invasive bladder cancer TROG 10.01 BOLART 2014
• A predictive model for dysphagia following IMRT for head and neck cancer: Introduction of the EMLasso technique 2013
• Late toxicity and biochemical control in 554 prostate cancer patients treated with and without dose escalated image guided radiotherapy 2013
• OC-0065: Small field dosimetry in flattening filter free (FFF) beams: comparison of diode, film and scintillation dosimeters 2013
• OC-0247: MOSkin detectors for on line in vivo dosimetry in HDR prostate brachytherapy 2013
• OC-0500: A national dosimetric audit of VMAT and Tomotherapy in the UK 2013
• PD-0231: Small field in-air output factors: miniphantom design and selection of dosimeter type 2013
• PD-0275: The influence of phase space and polarisation on MRT dose distributions 2013
• PO-0684: Assessment of target volume contour variability within a UK multicentre lung radiotherapy trial 2013
• PO-0779: Sensitivity of three commercial dosimeters to delivery errors in helical tomotherapy 2013
• Plan of the day selection for online image-guided adaptive post-prostatectomy radiotherapy 2013
• The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancer 2013
• The utility of e-learning to support training for a multicentre bladder online adaptive radiotherapy trial (trog 10.01-bolart) 2013
• Credentialing of radiotherapy centres for a clinical trial of adaptive radiotherapy for bladder cancer (TROG 10.01) 2012
• EP-1425 PRE-TRIAL PLANNING QA FOR THE IDEAL-CRT TRIAL: DOSE ESCALATION IN NSCLC 2012
• EP-1434 QUALITY ASSURANCE FOR CLINICAL TRIALS IN RADIOTHERAPY 2012
• EP-1509 ON THE SENSITIVITY OF PROSTATE RADIOTHERAPY TREATMENTS TO RANDOM UNCERTAINTIES; A COMPARISON OF TECHNIQUES 2012
• EP-1632 COMPARISON OF IMAGE REGISTRATION METHODS IN SUPINE BREAST RADIOTHERAPY TO MEASURE SET-UP ERRORS 2012
• Heterogeneity in head and neck IMRT target design and clinical practice 2012
• Is high-dose stereotactic body radiotherapy (SBRT) for stage i non-small cell lung cancer (NSCLC) overkill? A systematic review 2012
• OC-0505 A PREDICTIVE MODEL FOR DYSPHAGIA DURING IMRT IN HEAD AND NECK CANCER : INTRODUCTION OF THE EMLASSO TECHNIQUE 2012
• OC-0514 DIODE CORRECTION FACTORS IN SMALL FIELDS DETERMINED WITH AIR CORE FIBRE OPTIC SCINTILLATION DOSIMETER AND EBT2 FILM 2012
• OC-111 IMPROVED APPLICATOR VISUALISATION FOR MR-GUIDED BRACHYTHERAPY OF CERVIX 2012
• PD-0295 LATE TOXICITIES IN 796 PATIENTS AFTER CONVENTIONAL RADIATION THERAPY ALONE FOR NASOPHARYNGEAL CARCINOMA 2012
• PD-0326 COMMISSIONING OF A NEW WIDE BORE MRI SCANNER FOR RADIOTHERAPY PLANNING OF HEAD & NECK CANCER 2012
• PD-0530 PROTEOMIC IDENTIFICATION OF PUTATIVE BIOMARKERS OF RADIOTHERAPY RESISTANCE 2012
• PO-0690 INTERNAL TARGET VOLUME MARGINS FOR PROSTATE AND SEMINAL VESICLES ASSESSED WITH CINE-MRI 2012
• PO-0811 EVALUATING MOTION MANAGEMENT IN 3D USING MRI GEL DOSIMETRY 2012
• PO-0827 SMALL STATIC AND RAPIDARC FIELDS GENERATED BY MLC ONLY: MU CALCULATION ACCURACY FOR AAA AND ACUROS XB 2012
• PO-0869 A QUALITY ASSURANCE HEAD & NECK PHANTOM FOR TESTING DEFORMABLE REGISTRATION 2012
• 113 oral HOW MUCH EXPERIENCE IS ENOUGH? A COMPARATIVE ANALYSIS OF IMRT PLANS 2011
• 239 oral GEOMETRIC ADAPTATIONS TO AN ELECTRON GUN DESIGN FOR USE IN AN IN-LINE MRI-LINAC 2011
• 690 poster IMPLEMENTATION OF AN IMAGE GUIDED BRACHYTHERAPY (IGBT) SERVICE 2011
• Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy 2011
• In response to "the distribution of brain metastases in the perihippocampal region (Regarding Gondi et al., Radiother. Oncol. 2010; 95: 327-331) by van Kesteren et al 2011
• MRI-guided prostate radiation therapy planning: Investigation of dosimetric accuracy of MRI-based dose planning 2011
• PULSED REDUCED DOSE-RATE RADIOTHERAPY: AN IRRADIATION STRATEGY MINIMIZING NEUROCOGNITIVE LATE EFFECTS 2011
• Adaptive radiotherapy for bladder cancer reduces integral dose despite daily volumetric imaging 2010
• Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: Safety profile for RTOG 0933 2010
• Intra-fraction prostate displacement in radiotherapy estimated from pre- and post-treatment imaging of patients with implanted fiducial markers 2010
• Why avoid the hippocampus? A comprehensive review 2010
• 125 COMPARISON OF A NEW TOMOTHERAPY BASED STEREOTACTIC RADIOSURGERY PLANNING TECHNIQUE AND CONVENTIONAL PLANNING USING CIRCULAR COLLIMATORS 2009
• An in vivo investigative protocol for HDR prostate brachytherapy using urethral and rectal thermoluminescence dosimetry 2009
• Dose escalation model for limited-stage small-cell lung cancer 2009
• Lung 4D-IMRT treatment planning: An evaluation of three methods applied to four-dimensional data sets 2008
• On the dose to a moving target while employing different IMRT delivery mechanisms 2007
• A comparison of prostate IMRT and helical tomotherapy class solutions 2006
• Comparative planning evaluation of intensity-modulated radiotherapy techniques for complex lung cancer cases 2006
• Comparison of linac based fractionated stereotactic radiotherapy and tomotherapy treatment plans for skull-base tumors 2006
• The impact of dental metal artifacts on head and neck IMRT dose distributions 2006
• 84 Simultaneous infield boost with helical tomotherapy for patients with 1-3 brain metastases: A planning study 2005
• Correlation of 3D-planned and measured dosimetry of photon and electron craniospinal radiation in a pediatric anthropomorphic phantom 2005
• Tomotherapy planning of small brain tumours 2005
• Survival following whole brain radiation treatment for cerebral metastases: An audit of 474 patients 2004
• The effect of fraction time in intensity modulated radiotherapy: Theoretical and experimental evaluation of an optimization problem (the real conclusions): In regard to Mu et al. Radiotherapy on Oncology 2003; 68: 181-87 (multiple letters) 2004
• Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer 2003
• Optically guided intensity modulated radiotherapy 2001
• A timely reminder 2000
• An independent check of treatment plan, prescription and dose calculation as a QA procedure 1997
• Erythema: Goodbye LQ! 1997
• Response of human hair cortical cells to fractionated radiotherapy 1997
• 464In vivo skin dose measurements on breast patients using TLD extrapolation 1996
• Multicentre dosimetry study of mantle treatment in Australia and New Zealand 1996
• Underprediction of human skin erythema at low doses per fraction by the linear quadratic model 1996
• Clinical thermoluminescence dosimetry: how do expectations and results compare? 1993
• Post-operative radiotherapy in invasive thymoma 1991